Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIFAMPRIDINE for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where AMIFAMPRIDINE was used for Neoplasm.

Most Reported Side Effects for AMIFAMPRIDINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 298 12.3% 10 55
Asthenia 292 12.1% 23 110
Paraesthesia 260 10.7% 8 38
Paraesthesia oral 199 8.2% 3 21
Fall 194 8.0% 18 105
Nausea 168 6.9% 10 50
Muscular weakness 155 6.4% 10 55
Fatigue 154 6.4% 9 39
Condition aggravated 153 6.3% 9 63
Headache 149 6.2% 2 36
Dyspnoea 139 5.7% 12 74
Diarrhoea 134 5.5% 6 40
Dizziness 126 5.2% 1 21
Myasthenic syndrome 118 4.9% 19 57
Off label use 116 4.8% 6 24

Other Indications for AMIFAMPRIDINE

Myasthenic syndrome (2,164) Congenital myasthenic syndrome (74) Myasthenia gravis (39) Product used for unknown indication (35) Muscular weakness (9) Small cell lung cancer limited stage (6)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

AMIFAMPRIDINE Full Profile All Neoplasm Drugs AMIFAMPRIDINE Demographics AMIFAMPRIDINE Timeline